GGrantIndex
← Search

ADMINISTRATIVE CORE AND SENIOR LEADERSHIP

$351,142P30FY2017CANIH

Oregon Health & Science University, Portland OR

Investigators

Linked publications, trials & patents

Paper 39764100Paper 39763867Paper 39605535Paper 39435649Paper 39386578Paper 39375962Trial NCT07434128Trial NCT07278440Trial NCT07089940Trial NCT05705492Trial NCT04247425Trial NCT04172493Trial NCT04104139Trial NCT04061980Trial NCT04005690Trial NCT03961672Trial NCT03960177Trial NCT03699995Trial NCT03677531Trial NCT03649880Trial NCT03626285Trial NCT03613259Trial NCT03544125Trial NCT03479268Trial NCT03418025Trial NCT03406013Trial NCT03361436Trial NCT03347617Trial NCT03325166Trial NCT03280277Trial NCT03270059Trial NCT03261180Trial NCT03234309Trial NCT03135782Trial NCT03097588Trial NCT03028935Trial NCT03010358Trial NCT03009201Trial NCT02890979Trial NCT02869412Trial NCT02857218Trial NCT02779283Trial NCT02736617Trial NCT02522715Trial NCT02504359Trial NCT02503358Trial NCT02501759Trial NCT02498951Trial NCT02427841Trial NCT02359097Trial NCT02355262Trial NCT02312557Trial NCT02228265Trial NCT02100189Trial NCT02099864Trial NCT02092324Trial NCT02070705Trial NCT02050919Trial NCT01913015Trial NCT01748942Trial NCT01689987Trial NCT01649505Trial NCT01635413Trial NCT01620216Trial NCT01532687Trial NCT01498978Trial NCT01441882Trial NCT01422408Trial NCT01253642Trial NCT01031953Trial NCT01005914Trial NCT00983398Trial NCT00978562Trial NCT00900302Trial NCT00900068Trial NCT00900055Trial NCT00899795Trial NCT00899522Trial NCT00843167Trial NCT00822848Trial NCT00764517Trial NCT00722072Trial NCT00691652Trial NCT00662103Trial NCT00660543Trial NCT00659126Trial NCT00627276Trial NCT00516542Trial NCT00482274Trial NCT00425386Trial NCT00324324Trial NCT00303849Trial NCT00293475Trial NCT00253721Trial NCT00253643Trial NCT00238433Trial NCT00227682Trial NCT00103038Trial NCT00075387Patent 9279811

Abstract

ADMINISTRATION ABSTRACT The Knight Cancer Institute is a matrix organization within OHSU. The Cancer Center Support Grant (CCSG) has been effectively managed by the administrative office under the leadership of the OHSU Knight Cancer Institute Director, Brian Druker, M.D. The past several years have brought tremendous positive change to the cancer institute, including the appointment of world-renowned scientists to serve as Knight senior leaders, recruitment of 32 new cancer researchers, reorganization of research programs, development of an expanded vision for early cancer detection, and successful completion of a $1 billion philanthropic fundraising challenge campaign. The Knight administration plays a critical role in providing resources and expertise to support the strategic initiatives and ongoing operations of the Knight Cancer Institute. The Knight administrative team is led by Kristin Bialobok, Associate Director Administration, who oversees all central operations. Working to prevent duplication, and ensure integration and coordination with the larger OHSU structure, the Knight administrative office acts as a liaison to OHSU central service groups, divisions, and departments across campus. Key activities overseen by the Knight center administrative office include 1) fiscal and grants management; 2) shared resource oversight and support; 3) CCSG membership processes and activities; 4) space management; 3) planning and evaluation activities; 4) strategic communications; 5) business development and commercialization support; 6) information technology support and development; 7) general administration, human resources, and events coordination; 8) communication outreach and engagement; 9) pilot project administration, 10) faculty recruitment management; and 11) organizational development. In the current funding cycle, the Knight administrative team made multiple substantial contributions. Examples of these contributions include: 1) development of a scientific research advocate group; 2) creation and launching of a Community Partnership Initiative; 3) facilitation of design and construction preparation activities for a new Knight cancer research building and a new clinical building; 4) development of new Knight membership and publication tracking system (Galen); 5) implementation of a new Competitive Application Portal for management of internal funding opportunities and external limited submission applications; and 6) implementation of iLabs to streamline management of shared resources. The Knight senior leadership team is composed of Director, Brian Druker, MD; Deputy Director, Tomasz Beer, MD; and Associate Directors, Raymond Bergan, MD, Sara A. Courtneidge, PhD, Lisa M. Coussens, PhD, Joe Gray, PhD, Mary Stenzel-Poore, PhD, and Kristin Bialobok, MSN. Together these leaders are responsible for establishing the institute's goals, guiding its strategic initiatives, and ensuring that basic, translational, and population science initiatives are in alignment.

View original record on NIH RePORTER →